{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:46:39Z","timestamp":1777092399617,"version":"3.51.4"},"reference-count":75,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","award":["R21EB035261"],"award-info":[{"award-number":["R21EB035261"]}],"id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UM Life Sciences Institute"},{"name":"UM Biological Sciences Scholars Program"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Sentinel cells in the innate immune system decode combinations of pathogen-associated molecular patterns to shape immune responses, presenting an exploitable feature for vaccine adjuvants and cancer immunotherapies. Delivering innate immune agonists can direct responses toward patient-specific tumour antigens and enhance checkpoint blockade therapies. However, few adjuvants have been clinically approved, largely due to limited potencies or high toxicities. Key barriers remain in adjuvant design and translation: (i) reliance on single agonists, which poorly recapitulate complex pathogen sensing; (ii) poor understanding and control of synergistic effects among combined innate immune agonists; and (iii) a lack of scalable platforms for assembling diverse agonists. To address these issues, we developed polymeric RNAs (polyRNAs) as modular scaffolds that mimic pathogen structures and present multiple agonists. Synthesized by rolling circle transcription, polyRNAs achieve strong TLR3, TLR7, and RIG-I activation and can enable multivalent patterning of CpG-DNA for further engagement of TLR9 signalling. These polyRNA scaffolds are efficiently delivered with lipid nanoparticles and eliminate tumours in a syngeneic mouse model of colorectal cancer with comparable efficacies to clinical benchmarks. Our results establish polyRNAs as a programmable platform for combinatorial innate immune activation, with strong translational potential in cancer immunotherapy.<\/jats:p>","DOI":"10.1093\/nar\/gkag328","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:41:32Z","timestamp":1775043692000},"source":"Crossref","is-referenced-by-count":0,"title":["Engineering polymeric RNA scaffolds as programmable combinatorial innate immune agonists"],"prefix":"10.1093","volume":"54","author":[{"given":"Yinying","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]},{"name":"Life Sciences Institute, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew K","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Life Sciences Institute, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]},{"name":"Department of Pharmaceutical Sciences, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Life Sciences Institute, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]},{"name":"Department of Pharmaceutical Sciences, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias C D","family":"Issa","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]},{"name":"Life Sciences Institute, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Dorsey","sequence":"additional","affiliation":[{"name":"Life Sciences Institute, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4031-7286","authenticated-orcid":false,"given":"Connie","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]},{"name":"Life Sciences Institute, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]},{"name":"Department of Pharmaceutical Sciences, University of Michigan , Ann Arbor, MI 48109 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"2026042500213041600_B1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2026042500213041600_B2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2026042500213041600_B3","doi-asserted-by":"publisher","first-page":"617335","DOI":"10.3389\/fonc.2021.617335","article-title":"Progress and challenges of predictive biomarkers for immune checkpoint blockade","volume":"11","author":"Lei","year":"2021","journal-title":"Front Oncol"},{"key":"2026042500213041600_B4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine development for emerging infectious diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat Med"},{"key":"2026042500213041600_B5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","article-title":"Harnessing innate immunity in cancer therapy","volume":"574","author":"Demaria","year":"2019","journal-title":"Nature"},{"key":"2026042500213041600_B6","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.molonc.2015.10.016","article-title":"In situ vaccination: cancer immunotherapy both personalized and off-the-shelf","volume":"9","author":"Hammerich","year":"2015","journal-title":"Mol Oncol"},{"key":"2026042500213041600_B7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/14760584.2018.1434000","article-title":"Current challenges for cancer vaccine adjuvant development","volume":"17","author":"Bowen","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"2026042500213041600_B8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"2026042500213041600_B9","doi-asserted-by":"publisher","first-page":"615240","DOI":"10.3389\/fimmu.2020.615240","article-title":"Cancer vaccines: adjuvant potency, importance of age, lifestyle, and treatments","volume":"11","author":"Cuzzubbo","year":"2021","journal-title":"Front Immunol"},{"key":"2026042500213041600_B10","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"2026042500213041600_B11","doi-asserted-by":"publisher","first-page":"e10663","DOI":"10.1002\/btm2.10663","article-title":"Vaccine adjuvants for infectious disease in the clinic","volume":"9","author":"Goetz","year":"2024","journal-title":"Bioeng Transl Med"},{"key":"2026042500213041600_B12","doi-asserted-by":"publisher","first-page":"1544465","DOI":"10.3389\/fbiom.2025.1544465","article-title":"Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications","volume":"4","author":"Desai","year":"2025","journal-title":"Front Biomater Sci"},{"key":"2026042500213041600_B13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41565-022-01296-w","article-title":"A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion","volume":"18","author":"Jin","year":"2023","journal-title":"Nat Nanotechnol"},{"key":"2026042500213041600_B14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1021\/acscentsci.8b00823","article-title":"Linked toll-like receptor triagonists stimulate distinct, combination-dependent innate immune responses","volume":"5","author":"Albin","year":"2019","journal-title":"ACS Cent Sci"},{"key":"2026042500213041600_B15","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/s41565-024-01615-3","article-title":"Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination","volume":"19","author":"Zeng","year":"2024","journal-title":"Nat Nanotechnol"},{"key":"2026042500213041600_B16","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1021\/acsnano.0c10632","article-title":"Spatial regulation of t-cell signaling by programmed death-ligand 1 on wireframe DNA origami flat sheets","volume":"15","author":"Fang","year":"2021","journal-title":"ACS Nano"},{"key":"2026042500213041600_B17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nri2038","article-title":"Cooperation of Toll-like receptor signals in innate immune defence","volume":"7","author":"Trinchieri","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2026042500213041600_B18","doi-asserted-by":"publisher","first-page":"eado5937","DOI":"10.1126\/sciimmunol.ado5937","article-title":"Linking vaccine adjuvant mechanisms of action to function","volume":"10","author":"Ben-Akiva","year":"2025","journal-title":"Sci Immunol"},{"key":"2026042500213041600_B19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ni1223","article-title":"Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1\u2013polarizing program in dendritic cells","volume":"6","author":"Napolitani","year":"2005","journal-title":"Nat Immunol"},{"key":"2026042500213041600_B20","doi-asserted-by":"publisher","first-page":"2202393","DOI":"10.1002\/advs.202202393","article-title":"Self-assembly of immune signals to program innate immunity through rational adjuvant design","volume":"10","author":"Bookstaver","year":"2023","journal-title":"Adv Sci"},{"key":"2026042500213041600_B21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/B978-0-12-823901-8.00005-4","volume-title":"Cancer Vaccines as Immunotherapy of Cancer","author":"Hawthorne","year":"2022"},{"key":"2026042500213041600_B22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.it.2015.12.003","article-title":"Integration of innate immune signaling","volume":"37","author":"Thaiss","year":"2016","journal-title":"Trends Immunol"},{"key":"2026042500213041600_B23","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1021\/acsnano.3c09700","article-title":"Nanoparticle-conjugated toll-like receptor 9 agonists improve the potency, durability, and breadth of COVID-19 vaccines","volume":"18","author":"Ou","year":"2024","journal-title":"ACS Nano"},{"key":"2026042500213041600_B24","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.1021\/acs.biomac.0c00812","article-title":"Nanoparticles presenting potent TLR7\/8 agonists enhance anti-PD-L1 immunotherapy in cancer treatment","volume":"21","author":"Smith","year":"2020","journal-title":"Biomacromolecules"},{"key":"2026042500213041600_B25","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.bpj.2022.02.010","article-title":"Immobile ligands enhance Fc\u03b3R-TLR2\/1 crosstalk by promoting interface overlap of receptor clusters","volume":"121","author":"Li","year":"2022","journal-title":"Biophys J"},{"key":"2026042500213041600_B26","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.tibtech.2023.03.008","article-title":"Engineered macromolecular Toll-like receptor agents and assemblies","volume":"41","author":"Jackson\u00a0Hoffman","year":"2023","journal-title":"Trends Biotechnol"},{"key":"2026042500213041600_B27","doi-asserted-by":"publisher","first-page":"17629","DOI":"10.1074\/jbc.M116.741256","article-title":"Dectin-2 recognizes mannosylated O-antigens of human opportunistic pathogens and augments lipopolysaccharide activation of myeloid cells","volume":"291","author":"Wittmann","year":"2016","journal-title":"J Biol Chem"},{"key":"2026042500213041600_B28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41551-022-00973-4","article-title":"Induction of T-helper-17-cell-mediated anti-tumour immunity by pathogen-mimicking polymer nanoparticles","volume":"7","author":"Son","year":"2023","journal-title":"Nat Biomed Eng"},{"key":"2026042500213041600_B29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nrd.2018.132","article-title":"An RNA toolbox for cancer immunotherapy","volume":"17","author":"Pastor","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"2026042500213041600_B30","doi-asserted-by":"publisher","first-page":"6504","DOI":"10.1021\/acsnano.7b08777","article-title":"Rationally designed polycationic carriers for potent polymeric siRNA-mediated gene silencing","volume":"12","author":"Wu","year":"2018","journal-title":"ACS Nano"},{"key":"2026042500213041600_B31","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/nar\/gkv1488","article-title":"Periodic-shRNA molecules are capable of gene silencing, cytotoxicity and innate immune activation in cancer cells","volume":"44","author":"Shopsowitz","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026042500213041600_B32","doi-asserted-by":"publisher","first-page":"W605","DOI":"10.1093\/nar\/gki447","article-title":"Kinefold web server for RNA\/DNA folding path and structure prediction including pseudoknots and knots","volume":"33","author":"Xayaphoummine","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"2026042500213041600_B33","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/mt.2016.69","article-title":"Engineering periodic shRNA for enhanced silencing efficacy","volume":"24","author":"Wu","year":"2016","journal-title":"Mol Ther"},{"key":"2026042500213041600_B34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat Protoc"},{"key":"2026042500213041600_B35","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","article-title":"Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs","volume":"15","author":"Kauffman","year":"2015","journal-title":"Nano Lett"},{"key":"2026042500213041600_B36","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/mt.2013.124","article-title":"Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics","volume":"21","author":"Maier","year":"2013","journal-title":"Mol Ther"},{"key":"2026042500213041600_B37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1208\/s12248-021-00653-2","article-title":"Development of lipidoid nanoparticles for siRNA delivery to neural cells","volume":"24","author":"Khare","year":"2021","journal-title":"AAPS J"},{"key":"2026042500213041600_B38","doi-asserted-by":"crossref","first-page":"eabc2315","DOI":"10.1126\/sciadv.abc2315","article-title":"Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing","volume":"6","author":"Zhang","year":"2020","journal-title":"Sci Adv"},{"key":"2026042500213041600_B39","doi-asserted-by":"publisher","first-page":"8099","DOI":"10.1021\/acs.nanolett.5b03528","article-title":"An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo","volume":"15","author":"Li","year":"2015","journal-title":"Nano Lett"},{"key":"2026042500213041600_B40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.bbagrm.2009.06.005","article-title":"The Toll-like receptor 3:dsRNA signaling complex","volume":"1789","author":"Botos","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"2026042500213041600_B41","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1016\/j.celrep.2019.11.052","article-title":"RIG-I recognition of RNA Targets: the influence of terminal base pair sequence and overhangs on affinity and signaling","volume":"29","author":"Ren","year":"2019","journal-title":"Cell Rep"},{"key":"2026042500213041600_B42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-540-72167-3_4","volume-title":"Toll-Like Receptors (TLRs) and Innate Immunity","author":"Hornung","year":"2008"},{"key":"2026042500213041600_B43","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.immuni.2016.09.011","article-title":"Structural analysis reveals that toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA","volume":"45","author":"Zhang","year":"2016","journal-title":"Immunity"},{"key":"2026042500213041600_B44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bmc.2017.11.020","article-title":"TLR8 activation and inhibition by guanosine analogs in RNA: importance of functional groups and chain length","volume":"26","author":"Hu","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"2026042500213041600_B45","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1021\/acs.accounts.6b00417","article-title":"The discovery of rolling circle amplification and rolling circle transcription","volume":"49","author":"Mohsen","year":"2016","journal-title":"Acc Chem Res"},{"key":"2026042500213041600_B46","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1093\/nar\/gkg595","article-title":"Mfold web server for nucleic acid folding and hybridization prediction","volume":"31","author":"Zuker","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"2026042500213041600_B47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1073\/pnas.0710779105","article-title":"The TLR3 signaling complex forms by cooperative receptor dimerization","volume":"105","author":"Leonard","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026042500213041600_B48","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1126\/science.1155406","article-title":"Structural basis of toll-like receptor 3 signaling with double-stranded RNA","volume":"320","author":"Liu","year":"2008","journal-title":"Science"},{"key":"2026042500213041600_B49","doi-asserted-by":"publisher","first-page":"38133","DOI":"10.1074\/jbc.M507163200","article-title":"Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH","volume":"280","author":"de\u00a0Bouteiller","year":"2005","journal-title":"J Biol Chem"},{"key":"2026042500213041600_B50","doi-asserted-by":"publisher","first-page":"114990","DOI":"10.1016\/j.addr.2023.114990","article-title":"Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications","volume":"200","author":"Jeong","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"2026042500213041600_B51","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1021\/acs.molpharmaceut.2c00033","article-title":"Comparison of DLin-MC3-DMA and ALC-0315 for siRNA delivery to hepatocytes and hepatic stellate cells","volume":"19","author":"Ferraresso","year":"2022","journal-title":"Mol Pharmaceutics"},{"key":"2026042500213041600_B52","doi-asserted-by":"publisher","first-page":"e2214320120","DOI":"10.1073\/pnas.2214320120","article-title":"Comb-structured mRNA vaccine tethered with short double-stranded RNA adjuvants maximizes cellular immunity for cancer treatment","volume":"120","author":"Tockary","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026042500213041600_B53","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41467-023-36156-1","article-title":"3D RNA-scaffolded wireframe origami","volume":"14","author":"Parsons","year":"2023","journal-title":"Nat Commun"},{"key":"2026042500213041600_B54","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.15252\/embj.201488726","article-title":"Cytosolic RNA:DNA hybrids activate the cGAS-STING axis","volume":"33","author":"Mankan","year":"2014","journal-title":"EMBO J"},{"key":"2026042500213041600_B55","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide\u2013manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"2026042500213041600_B56","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res"},{"key":"2026042500213041600_B57","doi-asserted-by":"publisher","first-page":"16278","DOI":"10.1038\/s41598-019-52637-0","article-title":"Computational and NMR studies of RNA duplexes with an internal pseudouridine-adenosine base pair","volume":"9","author":"Deb","year":"2019","journal-title":"Sci Rep"},{"key":"2026042500213041600_B58","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1093\/nar\/gkt1330","article-title":"The contribution of pseudouridine to stabilities and structure of RNAs","volume":"42","author":"Kierzek","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"2026042500213041600_B59","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1016\/j.cell.2025.05.032","article-title":"Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement","volume":"188","author":"B\u00e9routi","year":"2025","journal-title":"Cell"},{"key":"2026042500213041600_B60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41551-021-00831-9","article-title":"Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity","volume":"6","author":"Agarwal","year":"2022","journal-title":"Nat Biomed Eng"},{"key":"2026042500213041600_B61","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41467-021-27390-6","article-title":"Maximizing response to intratumoral immunotherapy in mice by tuning local retention","volume":"13","author":"Momin","year":"2022","journal-title":"Nat Commun"},{"key":"2026042500213041600_B62","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1073\/pnas.0912986107","article-title":"LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses","volume":"107","author":"Satoh","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026042500213041600_B63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature04734","article-title":"Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses","volume":"441","author":"Kato","year":"2006","journal-title":"Nature"},{"key":"2026042500213041600_B64","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.addr.2013.05.013","article-title":"Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant","volume":"65","author":"Hafner","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"2026042500213041600_B65","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nm1176","article-title":"Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease","volume":"11","author":"Lang","year":"2005","journal-title":"Nat Med"},{"key":"2026042500213041600_B66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1600-065X.2008.00726.x","article-title":"Viral sensors: diversity in pathogen recognition","volume":"227","author":"McCartney","year":"2009","journal-title":"Immunol Rev"},{"key":"2026042500213041600_B67","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nature14138","article-title":"Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9","volume":"520","author":"Ohto","year":"2015","journal-title":"Nature"},{"key":"2026042500213041600_B68","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.1093\/nar\/gkp646","article-title":"Effect of salt and RNA structure on annealing and strand displacement by Hfq","volume":"37","author":"Hopkins","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"2026042500213041600_B69","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1021\/acsnano.3c07284","article-title":"RNA origami functions as a self-adjuvanted nanovaccine platform for cancer immunotherapy","volume":"18","author":"Yip","year":"2024","journal-title":"ACS Nano"},{"key":"2026042500213041600_B70","doi-asserted-by":"crossref","first-page":"114222","DOI":"10.1016\/j.ejpb.2024.114222","article-title":"Kinetics of RNA-LNP delivery and protein expression","volume":"197","author":"M\u00fcller","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"key":"2026042500213041600_B71","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1038\/s41565-025-01974-5","article-title":"Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape","volume":"20","author":"Omo-Lamai","year":"2025","journal-title":"Nat Nanotechnol"},{"key":"2026042500213041600_B72","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41551-023-01131-0","article-title":"Screening for lipid nanoparticles that modulate the immune activity of helper T cells towards enhanced antitumour activity","volume":"8","author":"Zhu","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"2026042500213041600_B73","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41551-024-01256-w","article-title":"Amine headgroups in ionizable lipids drive immune responses to lipid nanoparticles by binding to the receptors TLR4 and CD1d","volume":"8","author":"Chaudhary","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"2026042500213041600_B74","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.mattod.2025.07.028","article-title":"Advances in the rational design of ionizable lipids for mRNA therapeutics","volume":"89","author":"Lee","year":"2025","journal-title":"Mater Today"},{"key":"2026042500213041600_B75","doi-asserted-by":"publisher","first-page":"106234","DOI":"10.1016\/j.ejps.2022.106234","article-title":"Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways","volume":"176","author":"Tam","year":"2022","journal-title":"Eur J Pharm Sci"}],"container-title":["Nucleic Acids Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/54\/7\/gkag328\/68156848\/gkag328.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nar\/article-pdf\/54\/7\/gkag328\/68156848\/gkag328.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:21:40Z","timestamp":1777090900000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nar\/article\/doi\/10.1093\/nar\/gkag328\/8653596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":75,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4,13]]}},"URL":"https:\/\/doi.org\/10.1093\/nar\/gkag328","relation":{},"ISSN":["0305-1048","1362-4962"],"issn-type":[{"value":"0305-1048","type":"print"},{"value":"1362-4962","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,24]]},"published":{"date-parts":[[2026,4,13]]},"article-number":"gkag328"}}